{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:32:11Z","timestamp":1762446731572,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bonr.2022.101591","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T12:17:33Z","timestamp":1652876253000},"page":"101591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Growth hormone therapy in HHRH"],"prefix":"10.1016","volume":"16","author":[{"given":"Guido","family":"Filler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Schott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio Rosario","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher William","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Esther","family":"D\u00edaz Gonz\u00e1lez de Ferris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bonr.2022.101591_bb0005","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1210\/jc.2002-021787","article-title":"Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism","volume":"88","author":"Ahmad","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bonr.2022.101591_bb0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00424-018-2184-2","article-title":"Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy","volume":"471","author":"Bergwitz","year":"2019","journal-title":"Pflugers Arch."},{"issue":"6","key":"10.1016\/j.bonr.2022.101591_bb0015","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.ajkd.2018.12.026","article-title":"Fluconazole as a new therapeutic tool to manage patients with NPTIIc (SLC34A3) mutation: a case report","volume":"73","author":"Bertholet-Thomas","year":"2019","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.bonr.2022.101591_bb0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/BF00858154","article-title":"Assessment and interpretation of the tubular threshold for phosphate in infants and children","volume":"8","author":"Brodehl","year":"1994","journal-title":"Pediatr. Nephrol."},{"issue":"7","key":"10.1016\/j.bonr.2022.101591_bb0025","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00467-018-3945-z","article-title":"Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?","volume":"33","author":"Claramunt-Taberner","year":"2018","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bonr.2022.101591_bb0030","first-page":"1047327","article-title":"Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) presenting with genu valgum deformity: treatment with phosphate supplementation and surgical correction","volume":"2020","author":"Colazo","year":"2020","journal-title":"Case Rep. Endocrinol."},{"key":"10.1016\/j.bonr.2022.101591_bb0035","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1172\/JCI105036","article-title":"Effect of growth hormone on tubular transport of phosphate in normal and parathyroidectomized dogs","volume":"43","author":"Corvilain","year":"1964","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.bonr.2022.101591_bb0040","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1681\/ASN.2013101085","article-title":"Mutations in SLC34A3\/NPT2c are associated with kidney stones and nephrocalcinosis","volume":"25","author":"Dasgupta","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bonr.2022.101591_bb0045","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20912862","article-title":"Description of a novel SLC34A3.C.671delT mutation causing hereditary hypophosphatemic rickets with hypercalciuria in two adolescent boys and response to recombinant human growth hormone","volume":"12","author":"Dreimane","year":"2020","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"11","key":"10.1016\/j.bonr.2022.101591_bb0050","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1007\/s00467-021-05213-6","article-title":"Management of severe polyuria in idiopathic Fanconi syndrome","volume":"36","author":"Filler","year":"2021","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bonr.2022.101591_bb0055","first-page":"1","article-title":"Animal, human, and (23)Na MRI imaging evidence for the negative impact of high dietary salt in children","author":"Filler","year":"2021","journal-title":"Curr. Pediatr. Rep."},{"issue":"1","key":"10.1016\/j.bonr.2022.101591_bb0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s004240050759","article-title":"IGF-I and vanadate stimulate Na\/Pi-cotransport in OK cells by increasing type II Na\/Pi-cotransporter protein stability","volume":"437","author":"Jehle","year":"1998","journal-title":"Pflugers Arch."},{"issue":"2","key":"10.1016\/j.bonr.2022.101591_bb0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/499410","article-title":"Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3","volume":"78","author":"Lorenz-Depiereux","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.bonr.2022.101591_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031087","article-title":"Noncanonical sequences involving NHERF1 interaction with NPT2A govern hormone-regulated phosphate transport: binding outside the box","volume":"22","author":"Mamonova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bonr.2022.101591_bb0075","doi-asserted-by":"crossref","first-page":"F712","DOI":"10.1152\/ajprenal.00264.2020","article-title":"A role for tubular Na(+)\/H(+) exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin","volume":"319","author":"Onishi","year":"2020","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"4","key":"10.1016\/j.bonr.2022.101591_bb0080","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1542\/peds.100.4.675","article-title":"The relationship between urinary calcium, sodium, and potassium excretion and the role of potassium in treating idiopathic hypercalciuria","volume":"100","author":"Osorio","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.bonr.2022.101591_bb0085","article-title":"Tissue sodium concentrations in chronic kidney disease and dialysis patients by lower leg sodium-23 magnetic resonance imaging","author":"Qirjazi","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bonr.2022.101591_bb0090","article-title":"Effects of pediatric chronic kidney disease and its etiology on tissue sodium concentration: a pilot study","author":"Sarleno","year":"2022","journal-title":"Pediatr. Nephrol. TBA"},{"issue":"4","key":"10.1016\/j.bonr.2022.101591_bb0095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/ckj\/sfv028","article-title":"Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole","volume":"8","author":"Sayers","year":"2015","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.bonr.2022.101591_bb0100","article-title":"Recombinant growth hormone therapy for X-linked hypophosphatemia in children","volume":"10","author":"Smith","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.bonr.2022.101591_bb0105","doi-asserted-by":"crossref","first-page":"E423","DOI":"10.1210\/jc.2011-1935","article-title":"Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy","volume":"97","author":"Tebben","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bonr.2022.101591_bb0110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/tropej\/46.3.132","article-title":"Radiographic scoring method for the assessment of the severity of nutritional rickets","volume":"46","author":"Thacher","year":"2000","journal-title":"J. Trop. Pediatr."},{"issue":"1","key":"10.1016\/j.bonr.2022.101591_bb0115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00467-007-0584-1","article-title":"Report of a family with two different hereditary diseases leading to early nephrocalcinosis","volume":"23","author":"Vargas-Poussou","year":"2008","journal-title":"Pediatr. Nephrol."},{"issue":"5","key":"10.1016\/j.bonr.2022.101591_bb0120","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bone.2012.02.015","article-title":"Novel NaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families: long-term follow-up in one kindred","volume":"50","author":"Yu","year":"2012","journal-title":"Bone"}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187222004259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187222004259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:25:35Z","timestamp":1762446335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187222004259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":24,"alternative-id":["S2352187222004259"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2022.101591","relation":{},"ISSN":["2352-1872"],"issn-type":[{"type":"print","value":"2352-1872"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth hormone therapy in HHRH","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2022.101591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101591"}}